Women who have developed type 2 diabetes as a result of taking the prescription drug Lipitor, could be awarded monetary damages for their current and future medical needs
Georgetown, SC (PRWEB) June 05, 2013
A recently filed federal lawsuit in South Carolina (civil case no. 2:13-cv-796-CWH) is giving women who allegedly developed type 2 diabetes as a result of taking prescription Lipitor, a cholesterol lowering statin, a chance to be heard. South Carolina attorney, David L. Hood is currently reviewing Lipitor diabetes claims for this lawsuit that alleges that Lipitor increases a woman’s risk of getting diabetes, a side-effect that was not disclosed by Pfizer, the maker of Lipitor.
A study by University of Massachusetts Medical School researchers, published in the January 2012 medical journal "Archives of Internal Medicine", found that women between the ages of 50 and 79 who took statin medication were 48 percent more likely to develop type 2 diabetes than women who did not take the prescription medication. Other studies have also shown similar results.
In August 2011, the Division of Metabolism and Endocrinology of the FDA requested Pfizer make labeling changes for Lipitor based upon the FDA's comprehensive review. In February 2012, Pfizer complied with a FDA request and added the warning “Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor." This lawsuit alleges that the label still fails to warn consumers of the serious risk of developing type 2 diabetes.
“Many women allegedly in otherwise good health who were simply trying to reduce their levels of bad cholesterol (LDL) and increase their levels of good cholesterol (HDL) on Lipitor have found themselves with a devastating chronic health concern – type 2 diabetes,” said South Carolina attorney David L. Hood. “These allegedly innocent women now face a lifetime of monitoring their blood glucose levels, being on a strict diabetic diet and taking medication daily to try and control their diabetes. This lawsuit seeks to hold Pfizer accountable and seeks damages for the victims.”
In April of this year, a request was filed to consolidate the Lipitor diabetes litigation before one judge (MDL Docket No. 2459 JPDML). Consolidation will prevent duplicate discovery and inconsistent resolutions. Hood is currently reviewing Lipitor diabetes claims.
Plaintiffs across the country are filing Lipitor lawsuits, many of which are under consideration for consolidation into a federal multidistrict litigation for efficient pretrial proceedings (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (Judicial Panel on Multidistrict Litigation)).
“Women who have allegedly developed type 2 diabetes as a result of taking the prescription drug Lipitor, could be awarded monetary damages for their current and future medical needs,” said Hood.
For more information call (843) 527-8010 or visit HoodLawOffices.com.
About the Law Offices of David L. Hood
David L. Hood has been practicing law for over twenty years. He is admitted to all state and federal courts in South Carolina, with associate counsel licensed across the United States. The firm represents people who have been injured on the job or injured due to a product defect, denied social security disability benefits or were hurt in an accident. In addition, our firm represents the estates of people who have died due to accident or injury. David L. Hood has law offices in Georgetown, Murrells Inlet, Myrtle Beach, North Myrtle Beach, Conway, Mount Pleasant, and Charleston, South Carolina and associate counsel licensed across the United States. For more information, call (843) 527-8010 or visit HoodLawOffices.com.